Literature DB >> 14609719

Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex.

Mitsuhiro Fujihara1, Masashi Muroi, Ken-ichi Tanamoto, Tsuneo Suzuki, Hiroshi Azuma, Hisami Ikeda.   

Abstract

Bacterial lipopolysaccharide (LPS), the major structural component of the outer wall of Gram-negative bacteria, is a potent activator of macrophages. Activated macrophages produce a variety of inflammatory cytokines. Excessive production of cytokines in response to LPS is regarded as the cause of septic shock. On the other hand, macrophages exposed to suboptimal doses of LPS are rendered tolerant to subsequent exposure to LPS and manifest a profoundly altered response to LPS. Increasing evidence suggests that monocytic cells from patients with sepsis and septic shock survivors have characteristics of LPS tolerance. Thus, an understanding of the molecular mechanisms underlying activation and deactivation of macrophages in response to LPS is important for the development of therapeutics for septic shock and the treatment of septic shock survivors. Over the past several years, significant progress has been made in identifying and characterizing several key molecules and signal pathways involved in the regulation of macrophage functions by LPS. In this paper, we summarize the current findings of the functions of the LPS receptor complex, which is composed of CD14, Toll-like receptor 4 (TLR4), and myeloid differentiation protein-2 (MD-2), and the signal pathways of this LPS receptor complex with regard to both activation and deactivation of macrophages by LPS. In addition, recent therapeutic approaches for septic shock targeting the LPS receptor complex are described.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609719     DOI: 10.1016/j.pharmthera.2003.08.003

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  137 in total

1.  Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation.

Authors:  Neil R Aggarwal; Kenji Tsushima; Yoshiki Eto; Ashutosh Tripathi; Pooja Mandke; Jason R Mock; Brian T Garibaldi; Benjamin D Singer; Venkataramana K Sidhaye; Maureen R Horton; Landon S King; Franco R D'Alessio
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

2.  Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.

Authors:  Patrizia Carotenuto; Debby van Riel; André Artsen; Sven Bruijns; Fons G Uytdehaag; Jon D Laman; Andeltje B van Nunen; Pieter E Zondervan; Robert A De Man; Albert D Osterhaus; Oscar Pontesilli
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity.

Authors:  Natarajan Bhaskaran; Sanjeev Shukla; Janmejai K Srivastava; Sanjay Gupta
Journal:  Int J Mol Med       Date:  2010-12       Impact factor: 4.101

4.  Pulmonary intravascular macrophages and endotoxin-induced pulmonary pathophysiology in horses.

Authors:  Karin Aharonson-Raz; Baljit Singh
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

5.  Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.

Authors:  Yiguo Qiu; Pollob Kumar Shil; Ping Zhu; Hongxia Yang; Amrisha Verma; Bo Lei; Qiuhong Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

6.  Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia.

Authors:  Li C Chen; Ronald E Gordon; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2007-09-14       Impact factor: 3.362

7.  Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft.

Authors:  Yong Peng; Jian-Ping Gong; Chang-An Liu; Xu-Hong Li; Ling Gan; Shou-Bai Li
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

8.  Intravenous Glutamine Administration Modulates TNF-α/IL-10 Ratio and Attenuates NFkB Phosphorylation in a Protein Malnutrition Model.

Authors:  Andressa Cristina Antunes Santos; Carolina Argondizo Correia; Dalila Cunha de Oliveira; Amanda Nogueira-Pedro; Primavera Borelli; Ricardo Ambrosio Fock
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

9.  Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation.

Authors:  Lee W Hutson; Jennifer L Szczytkowski; Timothy B Saurer; Christina Lebonville; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2014-01-24       Impact factor: 7.217

Review 10.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.